(IN BRIEF) Researchers at the University of Exeter have been awarded nearly £400,000 from the Type 1 Diabetes Grand Challenge to explore innovative treatments for type 1 diabetes. Led by Dr. Craig Beall and Dr. Tom Piers, the project will … Read the full press release
(IN BRIEF) Lifecare, a Norwegian medtech company developing implantable sensors for glucose and biomarker monitoring, has transitioned from Euronext Growth Oslo to the main Euronext Oslo Børs market. This marks a significant milestone for the company, with a market capitalization … Read the full press release
(IN BRIEF) AstraZeneca and Ionis’ drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating hereditary transthyretin-mediated amyloidosis (ATTRv-PN) in adults with stage 1 or 2 polyneuropathy. Based on the positive results from the NEURO-TTRansform Phase … Read the full press release
Posted in Business, European Union, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Dr. Laura Obici, EU, Hereditary Amyloidosis (ATTRv-PN), Ionis Pharmaceuticals, safety, Wainzua
(IN BRIEF) GSK and the University of Cambridge have announced a £50 million, five-year collaboration called the Cambridge-GSK Translational Immunology Collaboration (CG-TIC) to accelerate research and development in kidney and respiratory diseases. The initiative combines GSK’s expertise in immunology and … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AI, Cambridge University, Cambridge-GSK Translational Immunology Collaboration (CG-TIC), GSK, immunology, investment, Kidney and Respiratory Diseases, Nicolas Wisniacki, partnership, Peter Kyle, Professor David Thomas, safety, sustainability, Tony Wood
(IN BRIEF) Novo Nordisk’s SOUL trial has shown that oral semaglutide reduces the risk of major adverse cardiovascular events (MACE) by 14% in adults with type 2 diabetes and established cardiovascular disease or chronic kidney disease. The trial involved 9,650 … Read the full press release
(IN BRIEF) Sanofi and CD&R have entered exclusive negotiations for CD&R to acquire a 50% controlling stake in Opella, Sanofi’s consumer healthcare business, while Sanofi retains a significant share. The partnership aims to support Opella’s growth as a global leader … Read the full press release
Posted in Business, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged acquisition, Allegra, CDR, Doliprane, expansion, France, Healthcare, Julie Van Ongevalle, Opella, partnership, Paul Hudson, Sanofi
(IN BRIEF) Novo Nordisk’s Alhemo® (concizumab) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). If approved, Alhemo® will become the first once-daily subcutaneous prophylactic treatment for people aged 12 … Read the full press release
Posted in Business, Denmark, Environment, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Alhemo®, Haemophilia A and B with Inhibitors, Novo Nordisk, Once-Daily Subcutaneous Treatment, safety, Stephanie Seremetis, sustainbility
(IN BRIEF) Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies (RLTs) for rare cancers. By combining their expertise, they aim to advance treatments using lead-212 (212Pb) alpha-emitting isotopes, which target and destroy cancer cells … Read the full press release
Posted in Business, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Cancer Therapies, Nicolas Maes, Orano Med, partnership, Paul Hudson, radioligand therapies (RLTs), rare cancers, safety, Sanofi, sustainability, USA
(IN BRIEF) Researchers at the Technical University of Munich (TUM) and TU Dresden are leading initiatives to develop 6G mobile communication technologies, with commercial availability expected by 2030. These projects focus on key advancements such as digital twins for reliable … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Security & Safety, Technology, Telecom
Tagged 6G Future Lab Bavaria, 6G Technology, 6G-life, Digital Twins, Holger Boche, Professors Wolfgang Kellerer, SECURITY, Technical University of Munich, Telediagnostics
HET NIEUWE INTELLISENSE AFIB-ALGORITME ONTDEKT MOGELIJKE ATRIUMFIBRILLATIE BIJ ELKE CONTROLE VAN DE BLOEDDRUK, VERBETERT VROEGE DETECTIE EN MOGELIJKE PREVENTIE VAN ERNSTIGE COMPLICATIES (IN HET KORT) OMRON Healthcare introduceert nieuwe bloeddrukmeters met een door AI aangedreven technologie voor het detecteren van … Read the full press release
Posted in Artificial Intelligence (AI), Electronics & Machinery, Healthcare, Netherlands, News, Pharma & Biotech, Technology
Tagged AFib, AFib-detectie, AI-aangedreven AFib-detectietechnologie, atriumfibrillatie, Ayumu Okada, bloeddruk, bloeddrukmeters, cardiogene cerebrale embolie, door AI aangestuurd algoritme, ESC2024, gezondheidstechnologie, hersenbloeding, HRS2024, Intellisense AFib, Intellisense AFib-algoritme, Lucia Prada, M6 Comfort AFib-, M7 Intelli IT AFib-, OMRON Healthcare, onregelmatige hartritmes, X7 smart AFib-, zelf monitoren van de gezondheid, zelflerende systemen
LE NOUVEL ALGORITHME INTELLISENSE AFIB DÉTECTE UNE ÉVENTUELLE FIBRILLATION AURICULAIRE LORS DE CHAQUE CONTRÔLE DE LA PRESSION ARTÉRIELLE, AMÉLIORANT AINSI LA DÉTECTION PRÉCOCE ET LA PRÉVENTION ÉVENTUELLE DE COMPLICATIONS GRAVES (ACTUALITÉ EN BREF) OMRON Healthcare a dévoilé une nouvelle gamme … Read the full press release
Posted in Artificial Intelligence (AI), Electronics & Machinery, France, Healthcare, Pharma & Biotech, Technology
Tagged accident vasculaire cérébral, algorithme alimenté par l’IA, algorithme Intellisense AFib, Ayumu Okada, détection de la fibrillation auriculaire alimentée par l’IA, ESC 2024, FA, fibrillation auriculaire, HRS 2024, Intellisense AFib, Lucia Prada, l’apprentissage automatique, l’autosurveillance de santé, M6 Comfort AFib, M7 Intelli IT AFib, mesure de la pression artérielle, OMRON Healthcare, patients hypertendus, pression artérielle, rythmes cardiaques irréguliers, surveillance médicale à domicile, technologies de la santé, tensiomètres, X7 smart AFib
IL NUOVO ALGORITMO INTELLISENSE AFIB RILEVA UNA POSSIBILE FIBRILLAZIONE ATRIALE AD OGNI CONTROLLO DELLA PRESSIONE SANGUIGNA, INCREMENTANDO LE POSSIBILITÀ DI RILEVAZIONE PRECOCE E PREVENZIONE DI COMPLICAZIONI POTENZIALMENTE GRAVI (NOTIZIA IN BREVE) OMRON Healthcare ha lanciato una nuova gamma di misuratori … Read the full press release
Posted in Artificial Intelligence (AI), Electronics & Machinery, Healthcare, Italy, Pharma & Biotech, Technology
Tagged AFib, algoritmo basato sull’IA, algoritmo Intellisense AFib, apparecchiature mediche, Ayumu Okada, cardiaco irregolare, cardiopatie, cardiovascolare, controllo della pressione sanguigna, embolia cerebrale cardiogena, ESC2024, fibrillazione atriale, gestione della salute, HRS2024, ictus, Intellisense AFib, l'apprendimento automatico, Lucia Prada, M6 Comfort AFib, M7 Intelli IT AFib, malattie cardiache, misuratori della pressione, monitoraggio della salute a domicilio, OMRON Healthcare, pazienti ipertesi, pressione sanguigna, Rilevamento AFib, rilevamento della fibrillazione atriale, rilevamento della fibrillazione atriale (AFib) basata sull’IA, rilevare una possibile fibrillazione atriale, ritmi cardiaci irregolari, tecnologia a scopo sanitario, tecnologia Intellisense AFib, X7 smart AFib, zero cardiovascolari, zero malattie cerebrovascolari
EL NUEVO ALGORITMO AFIB INTELLISENSE DETECTA UNA POSIBLE FIBRILACIÓN AURICULAR EN CADA CONTROL DE PRESIÓN, MEJORANDO LA DETECCIÓN TEMPRANA Y LA POSIBLE PREVENCIÓN DE COMPLICACIONES GRAVES (NOTICIA EN BREVE) OMRON Healthcare ha lanzado nuevos tensiómetros equipados con tecnología de detección … Read the full press release
Posted in Artificial Intelligence (AI), Electronics & Machinery, Healthcare, News, Pharma & Biotech, Spain, Technology
Tagged accidente cerebrovascular, accidente cerebrovascular cardioembólico, AFib Intellisense, algoritmo de Intellisense AFib, aprendizaje automático, autocontrol, Ayumu Okada, cardíacas, cardiopatías, cero cardiovasculares, cero enfermedades cerebrovasculares, control de la salud, control domiciliario de la salud, detección de fibrilación auricular, ESC2024, FA, fibrilación auricular, hipertensión, HRS2024, IA, Inteligencia artificial, Intellisense AFib, interrupciones en el pulso específicas de la FA, la gestión de afecciones cardiovasculares, la monitorización remota de pacientes, la Sra. Lucia Prada, latido irregular, los cuidados respiratorios, los dispositivos de terapia del dolor, M6 Comfort AFib, M7 Intelli IT AFib, OMRON, OMRON Healthcare, ritmo cardíaco irregular, tecnología médica, tensiómetros, tension, X7 smart AFib
(IN BRIEF) Researchers have identified the genetic variant HLA-DRB1*01:03, which is strongly linked to severe ulcerative colitis. About 3% of patients carry this variant, and of those, over 40% required major surgery within three years of diagnosis. (PRESS RELEASE) AALBORG, … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Aalborg University, Anne Krogh Nøhr, Genetic Marker, Henrik Krarup, HLA-DRB1*01:03, Kristine Allin, Lone Larsen, Marie Vibeke Vestergaard, Personalized Treatment, Professor Aleksejs Sazonovs, Severe Ulcerative Colitis, Tine Jess
(IN BRIEF) AstraZeneca presented significant advancements in the prevention of infectious diseases at IDWeek 2024, showcasing its dedication to addressing respiratory infections caused by RSV, hMPV, and COVID-19. The company revealed promising data across its portfolio, including Beyfortus, an antibody … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Media, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, Beyfortus, COVID-19, FluMist, hMPV, IDWeek 2024, Iskra Reic, IVX-A12, Respiratory Disease Prevention, RSV, safety, Vaccine Innovation
(IN BRIEF) Fresenius Medical Care’s subsidiary, Xenios AG, has launched Xenios 2.0, a new system for extracorporeal life support (ECLS) that serves patients from neonates to adults. Approved under the new Medical Device Regulation (MDR), Xenios 2.0 offers advanced safety … Read the full press release
Posted in Business, Electronics & Machinery, Financial, Germany, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Science, Technology
Tagged Connectivity Features, Dr. Benjamin Waldmann, extracorporeal life support (ECLS) System, Fresenius Medical Care, safety, Xenios 2.0, Xenios AG
(IN BRIEF) CompuGroup Medical (CGM) has appointed Dr. Thomas Speckmann as its Global Head of Communications, starting November 1, 2024. Dr. Speckmann, an experienced communications expert with a background in both politics and business, has previously worked with the Federal … Read the full press release
(IN BRIEF) Boehringer Ingelheim and the WHO Foundation have partnered to promote equitable healthcare access and suicide prevention, with a focus on vulnerable communities in the Americas. Boehringer Ingelheim pledged $5 million to support WHO’s 2025–2028 General Program of Work … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Society
Tagged Anil Soni, Boehringer Ingelheim, Global Healthcare Access, Médard Schoenmaeckers, mental health, partnership, society, Suicide Prevention Efforts, WHO Foundation
(IN BRIEF) The European Investment Bank (EIB Global) has committed €2 million to support Akagera Medicines Africa Limited in Rwanda, facilitating the early-stage development of vaccines for infectious diseases, including tuberculosis, HIV, Ebola, and Lassa fever. This funding aims to … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Science, Technology
Tagged Akagera Medicines, Belen Calvo Uyarra, Ebola, EIB Global, HIV, investment, Lassa fever, Michael Fairbanks, partnership, Regis Rugemanshuro, Rwanda, sustainability, Thomas Östros, tuberculosis, vaccine, wellness
(IN BRIEF) Eviden, a division of the Atos Group, has unveiled its “Cloud for Clinics,” a secure and pre-integrated platform tailored for healthcare providers in Germany and the DACH region, built on Amazon Web Services (AWS). This initiative aims to … Read the full press release
Posted in Business, Environment, Financial, France, Germany, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged "Cloud for Clinics" Platform, DACH region, Eviden, Healthcare, innovative, Max Peterson, Michael von Wagner, partnership, sustainability, Udo Littke
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?